
ExAblate Neuro
Spekman, Robert E....
ExAblate Neuro
Spekman, Robert E.; Thames, Matthew
M-0888 | Published June 29, 2015 | 20 pages Case
Collection: Darden School of Business
Product Details
This case examines InSightec, a company that had pioneered a therapeutic medical technology known as magnetic-resonance-guided focused ultrasound surgery with a product line named ExAblate. Further developing the technology to include brain treatments in a product called ExAblate Neuro, InSightec had the proprietary ability to safely penetrate the skull en route to a targeted lesion. Among other ailments, essential tremor (ET) appeared to be effectively treated in this manner. With FDA approval of ExAblate Neuro expected within two to three years, InSightec's VP of sales and marketing in the Americas was now tasked with devising a go-to-market strategy for the launch of this innovative new medical device in the complex and evolving U.S. health care market.
0
Get Ahead in Class

Clear, Complete, and Concise: Avoiding t...
Lipson, Marc L.

Business Valuation in Mergers and Acquis...
Schill, Michael J....

A Brief Introduction to Macroeconomics
Murphy, Daniel

Moral Theory, Frameworks, and the Langua...
Wicks, Andrew C.; ...

Three Empirical Methods for Calculating ...
Zhang, Zhihao; Whi...

The Basics of Multivariate Regressions i...
Batova, Tatiana

Advanced Tableau Tips and Tricks
Palomba, Anthony

Digital Marketing Metrics: Measuring Wha...
Venkatesan, Rajkum...

Disruption, Response, and Transformation...
Chen, Ming-Jer; Mc...

Using AI to Expand Your Leadership Commu...
Murray, Meghan

Understanding Organizational Culture: An...
Martin, Sean; Kemp...

A Brief Introduction to Managerial Accou...
Lynch, Luann J.

How to Prototype a Prototype
Chao, Raul O.

The Strategist’s Toolkit
Lenox, Michael; Ha...

Finance People
Schill, Michael J.